Cargando…
An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients
Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065338/ https://www.ncbi.nlm.nih.gov/pubmed/35515113 http://dx.doi.org/10.3389/fonc.2022.884724 |
_version_ | 1784699564301746176 |
---|---|
author | Scheichel, Florian Pinggera, Daniel Popadic, Branko Sherif, Camillo Marhold, Franz Freyschlag, Christian Franz |
author_facet | Scheichel, Florian Pinggera, Daniel Popadic, Branko Sherif, Camillo Marhold, Franz Freyschlag, Christian Franz |
author_sort | Scheichel, Florian |
collection | PubMed |
description | Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays a central role when reducing the diagnostic period is mandated. However, histopathological diagnosis could be complicated if the patient was preoperatively exposed to corticosteroids. Besides the histopathological result, diagnosis of a PCNSL also requires full diagnostic workup to exclude cerebral metastatic disease of a systemic lymphoma. Most reviews of PCNSL discuss recent advancements in systemic treatment options from an (neuro-)oncologic viewpoint, whereas our intention was to discuss the optimization of the diagnostic period and therefore describe current standards of imaging, summarizing the diagnostic workup, discussing the surgical workup and future diagnostic prospects as well as the influence of preoperative corticosteroid therapy to reduce the diagnostic delay of PCNSL patients. |
format | Online Article Text |
id | pubmed-9065338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-90653382022-05-04 An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients Scheichel, Florian Pinggera, Daniel Popadic, Branko Sherif, Camillo Marhold, Franz Freyschlag, Christian Franz Front Oncol Oncology Primary central nervous system lymphomas (PCNSL) are rare CNS tumors that harbor a conspicuously longer diagnostic delay compared to other malignant brain tumors. The gold standard for diagnosis is stereotactic biopsy to acquire tissue for histopathological analysis and therefore neurosurgery plays a central role when reducing the diagnostic period is mandated. However, histopathological diagnosis could be complicated if the patient was preoperatively exposed to corticosteroids. Besides the histopathological result, diagnosis of a PCNSL also requires full diagnostic workup to exclude cerebral metastatic disease of a systemic lymphoma. Most reviews of PCNSL discuss recent advancements in systemic treatment options from an (neuro-)oncologic viewpoint, whereas our intention was to discuss the optimization of the diagnostic period and therefore describe current standards of imaging, summarizing the diagnostic workup, discussing the surgical workup and future diagnostic prospects as well as the influence of preoperative corticosteroid therapy to reduce the diagnostic delay of PCNSL patients. Frontiers Media S.A. 2022-04-20 /pmc/articles/PMC9065338/ /pubmed/35515113 http://dx.doi.org/10.3389/fonc.2022.884724 Text en Copyright © 2022 Scheichel, Pinggera, Popadic, Sherif, Marhold and Freyschlag https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Scheichel, Florian Pinggera, Daniel Popadic, Branko Sherif, Camillo Marhold, Franz Freyschlag, Christian Franz An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients |
title | An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients |
title_full | An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients |
title_fullStr | An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients |
title_full_unstemmed | An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients |
title_short | An Update on Neurosurgical Management of Primary CNS Lymphoma in Immunocompetent Patients |
title_sort | update on neurosurgical management of primary cns lymphoma in immunocompetent patients |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065338/ https://www.ncbi.nlm.nih.gov/pubmed/35515113 http://dx.doi.org/10.3389/fonc.2022.884724 |
work_keys_str_mv | AT scheichelflorian anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT pinggeradaniel anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT popadicbranko anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT sherifcamillo anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT marholdfranz anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT freyschlagchristianfranz anupdateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT scheichelflorian updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT pinggeradaniel updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT popadicbranko updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT sherifcamillo updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT marholdfranz updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients AT freyschlagchristianfranz updateonneurosurgicalmanagementofprimarycnslymphomainimmunocompetentpatients |